The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EMERGING MARKETS-Latam stocks gain on vaccine optimism, FX rally peters out

Mon, 23rd Nov 2020 19:16

* Mexican peso at below 20 per dollar for first time since
March
* Peru preps century bond issue
* MSCI Latam stocks index up over 7% in last two weeks

(Adds details, updates prices)
By Sruthi Shankar and Ambar Warrick
Nov 23 (Reuters) - Latin American stocks rose on Monday,
while currencies retreated from initial gains as progress
towards a coronavirus vaccine bolstered hopes for economic
activity to return to pre-pandemic levels.
Bourses in Brazil, Chile and Mexico
rose between 0.8% to 1.4%, tracking a rally in global equities
after AstraZeneca said its COVID-19 vaccine, cheaper to
make, easier to distribute and faster to scale-up than its
rivals, could be as much as 90% effective.
Emerging market assets were cheered by the simpler
distribution logistics for the vaccine. Countries such as Brazil
and India already have supply and manufacturing contracts in
place for the vaccine.
Positive vaccine news, coupled with the prospect of easy
monetary policy for the duration of the pandemic has greatly
benefited equities, with the MSCI's index of regional equities
adding more than 7% over the past two weeks.
But regional currencies came off initial gains as investors
were still uncertain about the timing of a vaccine, while the
economic ructions from the pandemic continued to show. A
resurgence of infections in Brazil - Latam's largest economy -
also dulled risk appetite.
The real fell about 1%, while the Chilean peso
fell more than 1%, tracking a slight decline in copper prices.

Losses in the Mexican peso and the Colombian peso
were mitigated by strength in oil markets.
The Mexican unit fell slightly after briefly trading
below 20 to a dollar for the first time since March.
Renewed carry trade interest and relatively higher interest
rates have seen the peso outperform most of its emerging market
peers this year.
"The immediate target is MXN19.80," Marc Chandler, chief
market strategist at Bannockburn Global Forex told clients in a
note.
"The high nominal rates (~4.28% on a one-month bill, or
cetes) and the broader gains among emerging market currencies
appear to be fueling the peso's gains."
Peru's sol edged lower as the country prepared a
century bond in dollars after authorizing the issuance of debt
of up to $4 billion to help rein in the country's coronavirus
outbreak and soften its economic impact.
The issuance comes days after newly appointed interim
President Francisco Sagasti told Reuters that Peru planned to
issue bonds in the near term to service the Andean nation's
"very high" fiscal deficit.
Argentine markets were closed for a holiday.
Key Latin American stock indexes and currencies:

Latest Daily % change
MSCI Emerging Markets 1218.90 0.8

MSCI LatAm 2164.80 0.1

Brazil Bovespa 107178.68 1.07

Mexico IPC 42357.27 1.08

Chile IPSA 4131.91 1.91

Colombia COLCAP 1246.99 0.58


Currencies Latest Daily % change
Brazil real 5.4451 -1.09

Mexico peso 20.1343 -0.18

Chile peso 772.7 -1.14

Colombia peso 3645.55 -0.40
Peru sol 3.604 -0.26




(Reporting by Sruthi Shankar in Bengaluru; editing by Emelia
Sithole-Matarise and Tom Brown)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.